 Stacie Daugherty
Concepts (253)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Hypertension | 12 | 2024 | 1242 | 2.560 |
Why?
| | Out-of-Hospital Cardiac Arrest | 6 | 2024 | 70 | 2.310 |
Why?
| | Healthcare Disparities | 11 | 2021 | 575 | 2.080 |
Why?
| | Antihypertensive Agents | 8 | 2021 | 485 | 1.960 |
Why?
| | Sex Factors | 23 | 2024 | 1965 | 1.910 |
Why?
| | Cardiopulmonary Resuscitation | 6 | 2024 | 232 | 1.900 |
Why?
| | Medication Adherence | 5 | 2022 | 556 | 1.420 |
Why?
| | Exercise Test | 5 | 2017 | 612 | 1.330 |
Why?
| | Myocardial Infarction | 11 | 2017 | 1021 | 1.190 |
Why?
| | Cardiology | 7 | 2024 | 261 | 1.160 |
Why?
| | Racism | 4 | 2021 | 127 | 0.970 |
Why?
| | Registries | 20 | 2022 | 1895 | 0.950 |
Why?
| | Cardiovascular Diseases | 7 | 2024 | 2003 | 0.880 |
Why?
| | Heart Failure | 8 | 2022 | 2135 | 0.870 |
Why?
| | Practice Guidelines as Topic | 4 | 2019 | 1497 | 0.860 |
Why?
| | Coronary Disease | 3 | 2011 | 385 | 0.850 |
Why?
| | Blood Pressure | 5 | 2019 | 1736 | 0.810 |
Why?
| | Social Values | 2 | 2021 | 33 | 0.780 |
Why?
| | Risk Assessment | 7 | 2022 | 3232 | 0.770 |
Why?
| | Defibrillators, Implantable | 6 | 2019 | 300 | 0.720 |
Why?
| | Angiotensin-Converting Enzyme Inhibitors | 5 | 2018 | 198 | 0.710 |
Why?
| | Cardiologists | 2 | 2018 | 45 | 0.710 |
Why?
| | Multimodal Imaging | 5 | 2024 | 110 | 0.680 |
Why?
| | Myocardial Ischemia | 3 | 2022 | 258 | 0.650 |
Why?
| | Pregnancy Complications, Cardiovascular | 1 | 2020 | 78 | 0.640 |
Why?
| | United States | 33 | 2025 | 13826 | 0.630 |
Why?
| | Patient Acceptance of Health Care | 1 | 2025 | 757 | 0.610 |
Why?
| | Public Opinion | 1 | 2019 | 64 | 0.600 |
Why?
| | Death, Sudden, Cardiac | 4 | 2015 | 179 | 0.600 |
Why?
| | Middle Aged | 34 | 2025 | 31090 | 0.600 |
Why?
| | Female | 55 | 2025 | 68551 | 0.600 |
Why?
| | Primary Prevention | 4 | 2015 | 188 | 0.590 |
Why?
| | Clinical Decision-Making | 2 | 2018 | 301 | 0.590 |
Why?
| | Attitude to Health | 1 | 2021 | 430 | 0.590 |
Why?
| | Risk Factors | 18 | 2025 | 9745 | 0.580 |
Why?
| | Adrenergic beta-Antagonists | 5 | 2018 | 321 | 0.580 |
Why?
| | Radiography, Thoracic | 1 | 2019 | 166 | 0.580 |
Why?
| | Male | 49 | 2025 | 63512 | 0.570 |
Why?
| | Humans | 70 | 2025 | 129266 | 0.540 |
Why?
| | Sleep Wake Disorders | 1 | 2020 | 251 | 0.530 |
Why?
| | Hospitalization | 3 | 2025 | 2052 | 0.520 |
Why?
| | Warfarin | 1 | 2017 | 147 | 0.520 |
Why?
| | Thromboembolism | 1 | 2017 | 112 | 0.520 |
Why?
| | Disease Management | 2 | 2019 | 588 | 0.520 |
Why?
| | Anemia | 1 | 2017 | 160 | 0.520 |
Why?
| | Atrial Fibrillation | 2 | 2018 | 376 | 0.510 |
Why?
| | Follow-Up Studies | 13 | 2022 | 4887 | 0.500 |
Why?
| | Anticoagulants | 2 | 2018 | 636 | 0.500 |
Why?
| | Patient Discharge | 5 | 2022 | 835 | 0.500 |
Why?
| | Hemoglobins | 1 | 2017 | 339 | 0.490 |
Why?
| | Coronary Artery Disease | 5 | 2022 | 679 | 0.480 |
Why?
| | Ultrasonography | 1 | 2019 | 713 | 0.480 |
Why?
| | Sleep | 2 | 2022 | 684 | 0.470 |
Why?
| | Stroke | 4 | 2024 | 1070 | 0.470 |
Why?
| | Aged | 26 | 2024 | 22032 | 0.460 |
Why?
| | Quality of Health Care | 2 | 2020 | 602 | 0.450 |
Why?
| | Percutaneous Coronary Intervention | 3 | 2017 | 467 | 0.450 |
Why?
| | Ambulatory Care | 1 | 2018 | 504 | 0.440 |
Why?
| | Emergency Service, Hospital | 1 | 2025 | 1896 | 0.440 |
Why?
| | American Heart Association | 5 | 2020 | 296 | 0.440 |
Why?
| | Practice Patterns, Physicians' | 3 | 2018 | 1267 | 0.440 |
Why?
| | Guideline Adherence | 1 | 2018 | 526 | 0.440 |
Why?
| | Sex Distribution | 5 | 2020 | 359 | 0.420 |
Why?
| | Hemostasis, Surgical | 1 | 2013 | 22 | 0.420 |
Why?
| | Aged, 80 and over | 10 | 2021 | 7055 | 0.400 |
Why?
| | Blood Loss, Surgical | 1 | 2013 | 93 | 0.400 |
Why?
| | Health Status Disparities | 3 | 2021 | 251 | 0.390 |
Why?
| | Hydroxymethylglutaryl-CoA Reductase Inhibitors | 3 | 2017 | 430 | 0.390 |
Why?
| | Postoperative Hemorrhage | 1 | 2013 | 87 | 0.390 |
Why?
| | Drug Resistance | 1 | 2012 | 166 | 0.370 |
Why?
| | Patient Selection | 2 | 2013 | 662 | 0.320 |
Why?
| | Alaska Natives | 2 | 2022 | 138 | 0.320 |
Why?
| | Adult | 20 | 2025 | 35495 | 0.320 |
Why?
| | Resuscitation Orders | 2 | 2020 | 43 | 0.310 |
Why?
| | Patient Preference | 1 | 2011 | 184 | 0.310 |
Why?
| | Multivariate Analysis | 4 | 2017 | 1497 | 0.290 |
Why?
| | Electrocardiography | 1 | 2011 | 608 | 0.290 |
Why?
| | Societies, Medical | 4 | 2024 | 744 | 0.290 |
Why?
| | Incidence | 7 | 2022 | 2636 | 0.290 |
Why?
| | Cardiac Catheterization | 1 | 2011 | 518 | 0.280 |
Why?
| | Cohort Studies | 7 | 2025 | 5409 | 0.270 |
Why?
| | Aspirin | 2 | 2017 | 380 | 0.260 |
Why?
| | Retrospective Studies | 14 | 2024 | 14461 | 0.260 |
Why?
| | Coronary Angiography | 1 | 2008 | 305 | 0.250 |
Why?
| | Indians, North American | 2 | 2022 | 600 | 0.250 |
Why?
| | Lung | 1 | 2019 | 3927 | 0.250 |
Why?
| | Thoracic Surgery | 2 | 2017 | 122 | 0.250 |
Why?
| | Continuity of Patient Care | 1 | 2008 | 272 | 0.240 |
Why?
| | Heart Diseases | 2 | 2019 | 350 | 0.240 |
Why?
| | Young Adult | 11 | 2024 | 12391 | 0.240 |
Why?
| | Heart Arrest | 2 | 2020 | 320 | 0.240 |
Why?
| | Insurance, Health | 2 | 2025 | 265 | 0.230 |
Why?
| | Heart-Assist Devices | 2 | 2022 | 539 | 0.220 |
Why?
| | Touch Perception | 1 | 2024 | 16 | 0.220 |
Why?
| | Secondary Prevention | 2 | 2017 | 218 | 0.220 |
Why?
| | Health Knowledge, Attitudes, Practice | 3 | 2024 | 1276 | 0.220 |
Why?
| | Prospective Studies | 7 | 2019 | 7123 | 0.210 |
Why?
| | Housing | 1 | 2024 | 130 | 0.200 |
Why?
| | Odds Ratio | 5 | 2017 | 1019 | 0.200 |
Why?
| | Migraine Disorders | 1 | 2024 | 101 | 0.200 |
Why?
| | Prognosis | 6 | 2019 | 3773 | 0.200 |
Why?
| | Intention to Treat Analysis | 1 | 2021 | 68 | 0.190 |
Why?
| | Peptide Fragments | 2 | 2017 | 692 | 0.180 |
Why?
| | Single-Blind Method | 1 | 2021 | 271 | 0.180 |
Why?
| | Self Report | 2 | 2022 | 795 | 0.180 |
Why?
| | Hospital Mortality | 4 | 2018 | 846 | 0.180 |
Why?
| | Women's Health | 2 | 2016 | 364 | 0.180 |
Why?
| | Treatment Outcome | 10 | 2017 | 10202 | 0.170 |
Why?
| | Professional-Patient Relations | 1 | 2021 | 138 | 0.170 |
Why?
| | Writing | 1 | 2021 | 91 | 0.170 |
Why?
| | Telephone | 1 | 2021 | 167 | 0.170 |
Why?
| | Sex Characteristics | 5 | 2022 | 736 | 0.160 |
Why?
| | Drug Therapy, Combination | 2 | 2019 | 1040 | 0.160 |
Why?
| | Survival Rate | 5 | 2020 | 1869 | 0.160 |
Why?
| | Cardiac Resynchronization Therapy Devices | 1 | 2019 | 11 | 0.160 |
Why?
| | Sexuality | 1 | 2019 | 30 | 0.150 |
Why?
| | Electric Countershock | 1 | 2019 | 105 | 0.150 |
Why?
| | Oropharyngeal Neoplasms | 1 | 2019 | 48 | 0.150 |
Why?
| | Prevalence | 3 | 2024 | 2553 | 0.150 |
Why?
| | Colorado | 3 | 2021 | 4406 | 0.150 |
Why?
| | Time Factors | 6 | 2018 | 6543 | 0.150 |
Why?
| | Congresses as Topic | 1 | 2020 | 216 | 0.150 |
Why?
| | Clinical Audit | 1 | 2018 | 11 | 0.150 |
Why?
| | Ventricular Function | 1 | 2018 | 61 | 0.150 |
Why?
| | Heart Failure, Diastolic | 1 | 2018 | 21 | 0.150 |
Why?
| | Logistic Models | 4 | 2012 | 1985 | 0.150 |
Why?
| | Predictive Value of Tests | 3 | 2019 | 1949 | 0.150 |
Why?
| | Heart Failure, Systolic | 1 | 2018 | 25 | 0.150 |
Why?
| | Postmenopause | 1 | 2020 | 350 | 0.140 |
Why?
| | Patient Readmission | 2 | 2020 | 652 | 0.140 |
Why?
| | Residence Characteristics | 1 | 2020 | 327 | 0.140 |
Why?
| | Atherosclerosis | 1 | 2022 | 402 | 0.140 |
Why?
| | F Factor | 1 | 2017 | 3 | 0.140 |
Why?
| | Positron-Emission Tomography | 1 | 2019 | 286 | 0.140 |
Why?
| | Transgender Persons | 1 | 2020 | 172 | 0.140 |
Why?
| | Anesthesiology | 1 | 2017 | 45 | 0.140 |
Why?
| | Angiotensin II Type 1 Receptor Blockers | 2 | 2017 | 36 | 0.140 |
Why?
| | Ezetimibe | 1 | 2017 | 25 | 0.140 |
Why?
| | Point-of-Care Systems | 1 | 2019 | 147 | 0.140 |
Why?
| | Simvastatin | 1 | 2017 | 60 | 0.140 |
Why?
| | Health Care Surveys | 1 | 2019 | 557 | 0.130 |
Why?
| | Poverty | 1 | 2020 | 496 | 0.130 |
Why?
| | Natriuretic Peptide, Brain | 1 | 2017 | 99 | 0.130 |
Why?
| | Mortality | 2 | 2008 | 307 | 0.130 |
Why?
| | Chi-Square Distribution | 1 | 2017 | 514 | 0.130 |
Why?
| | Sex Offenses | 1 | 2019 | 176 | 0.130 |
Why?
| | Patient Protection and Affordable Care Act | 1 | 2017 | 98 | 0.130 |
Why?
| | Heart Valve Diseases | 1 | 2017 | 152 | 0.130 |
Why?
| | Blood Pressure Determination | 2 | 2014 | 148 | 0.120 |
Why?
| | Anticholesteremic Agents | 1 | 2017 | 150 | 0.120 |
Why?
| | Administration, Oral | 1 | 2017 | 785 | 0.120 |
Why?
| | Diagnostic Imaging | 1 | 2017 | 327 | 0.120 |
Why?
| | Aortic Valve Stenosis | 1 | 2017 | 218 | 0.120 |
Why?
| | Waiting Lists | 1 | 2017 | 237 | 0.120 |
Why?
| | Communication | 2 | 2018 | 836 | 0.120 |
Why?
| | Ambulatory Care Facilities | 2 | 2020 | 226 | 0.120 |
Why?
| | Angiography | 3 | 2020 | 196 | 0.110 |
Why?
| | Acute Coronary Syndrome | 1 | 2017 | 267 | 0.110 |
Why?
| | Heart Defects, Congenital | 1 | 2020 | 757 | 0.110 |
Why?
| | Decision Support Techniques | 1 | 2017 | 395 | 0.100 |
Why?
| | Referral and Consultation | 1 | 2019 | 727 | 0.100 |
Why?
| | Critical Care | 1 | 2018 | 551 | 0.100 |
Why?
| | Obesity | 2 | 2024 | 2879 | 0.100 |
Why?
| | Hemorrhage | 1 | 2017 | 678 | 0.100 |
Why?
| | Hirudins | 1 | 2013 | 52 | 0.100 |
Why?
| | Antithrombins | 1 | 2013 | 58 | 0.100 |
Why?
| | Medicaid | 1 | 2017 | 431 | 0.100 |
Why?
| | Depression | 1 | 2021 | 1306 | 0.100 |
Why?
| | Diuretics | 1 | 2012 | 75 | 0.100 |
Why?
| | Health Personnel | 1 | 2018 | 648 | 0.100 |
Why?
| | Echocardiography | 3 | 2020 | 629 | 0.090 |
Why?
| | Dose-Response Relationship, Drug | 2 | 2013 | 2011 | 0.090 |
Why?
| | Heart Transplantation | 1 | 2017 | 721 | 0.090 |
Why?
| | Stroke Volume | 1 | 2013 | 592 | 0.080 |
Why?
| | Recombinant Proteins | 1 | 2013 | 1304 | 0.080 |
Why?
| | Age Factors | 4 | 2022 | 3140 | 0.080 |
Why?
| | Aftercare | 2 | 2022 | 203 | 0.080 |
Why?
| | Hospitals | 1 | 2014 | 630 | 0.080 |
Why?
| | Biomarkers | 2 | 2017 | 3968 | 0.080 |
Why?
| | Eligibility Determination | 1 | 2009 | 63 | 0.080 |
Why?
| | Medicare | 3 | 2022 | 706 | 0.080 |
Why?
| | Tomography, X-Ray Computed | 4 | 2020 | 2515 | 0.080 |
Why?
| | Proportional Hazards Models | 2 | 2008 | 1197 | 0.070 |
Why?
| | Poisson Distribution | 1 | 2008 | 73 | 0.070 |
Why?
| | Cross-Sectional Studies | 3 | 2024 | 5050 | 0.070 |
Why?
| | Pregnancy | 1 | 2020 | 6390 | 0.070 |
Why?
| | Magnetic Resonance Imaging, Cine | 2 | 2017 | 185 | 0.070 |
Why?
| | Veterans | 1 | 2017 | 1374 | 0.060 |
Why?
| | Regression Analysis | 1 | 2008 | 991 | 0.060 |
Why?
| | Longitudinal Studies | 1 | 2012 | 2715 | 0.060 |
Why?
| | Adolescent | 6 | 2022 | 20313 | 0.060 |
Why?
| | Recovery of Function | 1 | 2008 | 641 | 0.060 |
Why?
| | Heart Rate | 1 | 2008 | 802 | 0.060 |
Why?
| | Evidence-Based Medicine | 1 | 2008 | 712 | 0.050 |
Why?
| | Primary Health Care | 1 | 2014 | 1678 | 0.050 |
Why?
| | Pilot Projects | 2 | 2020 | 1584 | 0.050 |
Why?
| | Surgical Procedures, Operative | 1 | 2024 | 244 | 0.050 |
Why?
| | Alaska | 1 | 2021 | 82 | 0.050 |
Why?
| | Risk Reduction Behavior | 1 | 2022 | 209 | 0.040 |
Why?
| | Cholesterol | 1 | 2022 | 412 | 0.040 |
Why?
| | Gender Identity | 1 | 2020 | 117 | 0.040 |
Why?
| | Surveys and Questionnaires | 2 | 2024 | 5384 | 0.040 |
Why?
| | Age Distribution | 1 | 2020 | 372 | 0.040 |
Why?
| | Diabetes Mellitus, Type 2 | 1 | 2014 | 2439 | 0.040 |
Why?
| | Perception | 1 | 2021 | 337 | 0.040 |
Why?
| | Magnetic Resonance Spectroscopy | 1 | 2020 | 538 | 0.040 |
Why?
| | SEER Program | 1 | 2019 | 202 | 0.040 |
Why?
| | Minority Health | 1 | 2018 | 19 | 0.040 |
Why?
| | Hospitals, Rural | 1 | 2018 | 37 | 0.040 |
Why?
| | California | 1 | 2019 | 400 | 0.040 |
Why?
| | Hospitals, Urban | 1 | 2018 | 129 | 0.040 |
Why?
| | Postoperative Complications | 1 | 2009 | 2473 | 0.030 |
Why?
| | Advisory Committees | 1 | 2019 | 216 | 0.030 |
Why?
| | Risk Adjustment | 1 | 2017 | 79 | 0.030 |
Why?
| | Exercise | 1 | 2008 | 1925 | 0.030 |
Why?
| | Europe | 1 | 2017 | 363 | 0.030 |
Why?
| | Needs Assessment | 1 | 2019 | 359 | 0.030 |
Why?
| | Prosthesis Design | 1 | 2018 | 306 | 0.030 |
Why?
| | Case-Control Studies | 1 | 2024 | 3377 | 0.030 |
Why?
| | Medically Uninsured | 1 | 2017 | 126 | 0.030 |
Why?
| | Consensus | 1 | 2019 | 615 | 0.030 |
Why?
| | Body Mass Index | 1 | 2024 | 2272 | 0.030 |
Why?
| | Veterans Health | 1 | 2017 | 177 | 0.030 |
Why?
| | Insurance Coverage | 1 | 2017 | 218 | 0.030 |
Why?
| | Caregivers | 1 | 2022 | 809 | 0.030 |
Why?
| | Frail Elderly | 1 | 2015 | 121 | 0.030 |
Why?
| | Survival Analysis | 1 | 2017 | 1269 | 0.030 |
Why?
| | Linear Models | 1 | 2017 | 819 | 0.030 |
Why?
| | Radial Artery | 1 | 2014 | 69 | 0.030 |
Why?
| | Liver Cirrhosis | 1 | 2015 | 279 | 0.030 |
Why?
| | Platelet Aggregation Inhibitors | 1 | 2017 | 442 | 0.030 |
Why?
| | Physician-Patient Relations | 1 | 2018 | 538 | 0.030 |
Why?
| | Intensive Care Units | 1 | 2018 | 736 | 0.030 |
Why?
| | United States Department of Veterans Affairs | 1 | 2017 | 623 | 0.030 |
Why?
| | Dementia | 1 | 2015 | 225 | 0.020 |
Why?
| | Clinical Trials as Topic | 1 | 2017 | 1004 | 0.020 |
Why?
| | Comorbidity | 1 | 2017 | 1544 | 0.020 |
Why?
| | Cholesterol, LDL | 1 | 2014 | 358 | 0.020 |
Why?
| | Qualitative Research | 1 | 2018 | 1215 | 0.020 |
Why?
| | Reproducibility of Results | 1 | 2019 | 3080 | 0.020 |
Why?
| | Delivery of Health Care, Integrated | 1 | 2014 | 248 | 0.020 |
Why?
| | Attitude of Health Personnel | 1 | 2018 | 1094 | 0.020 |
Why?
| | Renal Insufficiency, Chronic | 1 | 2015 | 566 | 0.020 |
Why?
| | Socioeconomic Factors | 1 | 2014 | 1209 | 0.020 |
Why?
| | Obstetrics | 1 | 2011 | 160 | 0.020 |
Why?
| | Gynecology | 1 | 2011 | 174 | 0.020 |
Why?
| | Pulmonary Disease, Chronic Obstructive | 1 | 2015 | 983 | 0.020 |
Why?
| | Diabetes Mellitus | 1 | 2015 | 1000 | 0.020 |
Why?
| | Magnetic Resonance Imaging | 1 | 2019 | 3386 | 0.020 |
Why?
| | Cause of Death | 1 | 2008 | 392 | 0.020 |
Why?
| | Insulin | 1 | 2014 | 2325 | 0.010 |
Why?
| | Neoplasms | 1 | 2015 | 2449 | 0.010 |
Why?
| | Child | 1 | 2020 | 20785 | 0.010 |
Why?
|
|
Daugherty's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|